Components of rhizome extract of Cnidium officinale makino and their in vitro biological effects

Molecules

Volumn 16, Issue 10, 2011, Pages 8833-8847

  Bae, Ki Eun ^a   Choi, Young Woong ^a   Kim, Sang Tae ^a   Kim, Young Kyoon ^a  

^a Kookmin University   (South Korea)

Author keywords

Bax, p53; Bcl 2; Cyclooxygenase 2 (COX 2); Falcarindiol; Nitric oxide synthase (NOS)

Indexed keywords

3 N BUTYL 4,5 DIHYDROPHTHALIDE; 3-N-BUTYL-4,5-DIHYDROPHTHALIDE; ALKYNE DERIVATIVE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BENZOFURAN DERIVATIVE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FALCARINDIOL; FATTY ALCOHOL; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; PROTEIN BAX; PROTEIN P53;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHEMISTRY; CNIDIUM; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MOUSE; RHIZOME; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOFURANS; BREAST NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CNIDIUM; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DIYNES; FATTY ALCOHOLS; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; RHIZOME; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80054933069     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16108833     Document Type: Article

References (24)

1. Park, J. H.; Lee, J. G. The Encyclopedia of Medicinal Plants; Sin-il: Seoul, Korea, 2000; p. 418.
2. Kim, M. S. L.; Choi, H. S.; Sawamura, M. Constituents of the essential oil of cnidium officinale Makino, a Korean medicinal plant. Flavour. Frag. J. 2002, 17, 49-53.
3. Tahara, E.; Satoh, T.; Toriizuka, K.; Nagai, H.; Nunome, S.; Shimada, Y.; Itoh, T.; Terasawa, K.; Saiki, I. Effect of Shimotsu-to (a Kampo medicine, Si-Wu-Tang) and its constituents on triphasic skin reaction in passively sensitized mice. J. Ethnopharmacol. 1999, 68, 219-228. (Pubitemid 29502478)
4. Wang, J. D.; Narui, T.; Kurata, H.; Takeuchi, K.; Hashimoto, T.; Okuyama, T. Hematological studies on naturally occurring substances. II. Effects of animal crude drugs on blood coagulation and fibrinolysis systems. Chem. Pharm. Bull. (Tokyo) 1989, 37, 2236-2238. (Pubitemid 19226542)
5. Higashi, K. The therapeutic effect of Unsei-in on facial redness (inflammatory congestion) in atopic dermatitis. Jpn. J. Oriental Med. 1996, 46, 753-760.
6. Haranaka, K.; Satomi, N.; Sakurai, A.; Haranaka, R.; Okada, N.; Kobayashi, M. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immun. Immunother. 1985, 20, 1-5. (Pubitemid 15238915)
7. Onishi, Y.; Yamaura, T.; Tauchi, K.; Sakamoto, T.; Tsukada, K.; Nunome, S.; Komatsu, Y.; Saiki, I. Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents. Biol. Pharm. Bull. 1998, 21, 761-5. (Pubitemid 28374454)
8. Halliwell, B.; Gutteridge, J. M. Role of free radicals and catalytic metal ions in human disease: An overview. Meth. Enzymol. 1990, 186, 1-85. (Pubitemid 20279941)
9. Schumacker, P. T. Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell 2006, 10, 175-176. (Pubitemid 44311072)
10. Beal, M. F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 1995, 38, 357-366.
11. Ames, B. N.; Shigenaga, M. K.; Hagen, T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 1993, 90, 7915-7922. (Pubitemid 23260825)
12. Leung, P. S.; Chan, Y. C. Role of oxidative stress in pancreatic inflammation. Antioxid. Redox Signal. 2009, 11, 135-165.
13. Lawless, M. W.; O'Byrne, K. J.; Gray, S. G. Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy. J. Cell. Mol. Med. 2009, 13, 2800-2821.
14. Goldstein, M. G.; Li, Z. Heat-shock proteins in infection-mediated inflammation-induced tumorigenesis. J. Hematol. Oncol. 2009, 2, 5.
15. Trachootham, D.; Alexandre, J.; Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 2009, 8, 579-591.
16. Kundu, J. K.; Surh, Y. J. Inflammation: Gearing the journey to cancer. Mutat. Res. 2008, 659, 15-30.
17. Reddy, L.; Odhav, B.; Bhoola, K. D. Natural products for cancer prevention: A global perspective. Pharmacol. Ther. 2003, 99, 1-13. (Pubitemid 36694746)
18. Mann, J. Natural products in cancer chemotherapy: Past, present and future. Nat. Rev. Cancer 2002, 2, 143-148. (Pubitemid 37328801)
19. Deng, S. Phytochemical investigation of bioactive constituents from angelica sinesis. Ph. D. Thesis, University of Illinois, Chicago, IL, USA, 2005.
20. Grech, J. N.; Li, Q.; Roufogalis, B. D.; Duck, C. C. Novel Ca (2+)-ATPase inhibitors from the dried root tubers of Polygonum Multiflorum. J. Nat. Prod. 1994, 57, 1682-1687.
21. Kobayashi, M.; Fujita, M.; Mitsuhashi, H. Components of Cnidium officinale Makino: Occurrence of pregnenolone, coniferyl ferulate, and hydroxyphthalides. Chem. Pharm. Bull. (Tokyo) 1984, 32, 3770-3773. (Pubitemid 14015781)
22. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63. (Pubitemid 14203433)
23. Green, L. C.; Wagner, D. A.; Glogowski, J.; Skipper, P. L.; Wishnok, J. S.; Tannenbaum, S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126, 131-138. (Pubitemid 13203451)
24. Lee, K. W.; Kim, H. J.; Lee, Y. S.; Park, H. J.; Choi, J. W.; Ha, J.; Lee, K. T. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. Carcinogenesis 2007, 28, 1928-1936. (Pubitemid 47500605)